For the Ad5-based OA CRAd-Survivin-pk7, the native E1 promoter was deleted to avoid viral replication in normal cells, and the human survivin promoter, termed CRAd-S, was inserted to drive E1 expression, resulting in the gliomas-specific replication (NCT03072134) [35]. This evidence concerns the gene BIRC5 and central nervous system cancer.